Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

NeuroGenetic Pharma
445 Marine View Ave., Suite 101
Del Mar, CA 92014
Phone: 858-461-4480
www.neurogeneticpharmaceuticals.com

NeuroGenetic Pharmaceuticals, Inc. (NGP), a biopharmaceutical discovery and development company founded in 2009, is developing innovative drug therapies for Alzheimer's disease. Based in San Diego, Calif., the company's next objective is to obtain an Investigational New Drug approval for its clinical candidate, NGP 555. Future clinical trials will utilize specific amyloid biomarkers and/or brain scanning as an early diagnostic and to monitor drug efficacy in clinical trials. Combining early disease identification with a treatment capable of preventing AD-related pathology, such as NGP 555, would represent an important advance in our ability to prevent AD or hinder its progression to dementia.

Key Contact
Name
Dr. William T. Comer
Title
CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
Valuation
01/04/12 undisclosed Strategic Abbott Biotech Ventures
undisclosed